Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2023

  1. Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study

    The Lancet. Oncology, Vol. 24, Núm. 12, pp. 1411-1422